Our plain-English summary of Real-time autOmatically updated data warehOuse in healThcare (ROOT): an innovative and automated data collection system, by H.A. Jung, O. Jeong, D.K. Chang, et al (Translational Lung Cancer Research, 2021).
You don't need the product names or old records. No fee unless we recover compensation for your family.
The study
- Authors: H.A. Jung, O. Jeong, D.K. Chang, S. Park, J.M. Sun, S.H. Lee, J.S. Ahn, M.J. Ahn, K. Park
- Journal: Translational Lung Cancer Research
- Published: 2021;10(10):3865-3874
- Cited by: 13 articles, as counted by NIH iCite
- Read it: PubMed · Publisher · Free full text
Abstract
Background: The American Society for Clinical Oncology recently launched the minimal common oncology data elements project to facilitate cancer data interoperability. However, clinical data are often unrecorded in an organized way, and converting them into a structured format can be time-consuming. Clinical Data Warehouse (CDW) is a database that consolidates data from different clinical sources. However, the clinical data extracted from this database include not only structured data but also natural language generated during clinical practice. Therefore, applying these data to a clinical study is challenging because they are unstructured, and unformatted to allow essential content to be found. This study determined how best to organize a huge amount of clinical data to evaluate the upper aerodigestive tract cancers' clinical features and outcomes, including cancer of the head and neck, esophagus, lung, thymus, and mesothelioma.
Methods: The Real-time autOmatically updated data warehOuse in healThcare (ROOT) uses six main regions to describe the journey of cancer patients. This study, developed an algorithm optimized for each disease category using natural language processing of unstructured data and data capture of structured data. Data from patients diagnosed at the Samsung Medical Center from 2008-2020 were used.
Results: Comprehensive clinical data for 67,617 patients across six tumor types: 28,954 with non-small-cell lung cancer, 2,540 with small-cell lung cancer, 30,035 with head and neck cancer, 4,950 with esophageal cancer, 966 with thymic cancer, and 172 with mesothelioma were collected. Additionally, the results of a longitudinal molecular study, including epidermal growth factor receptor (EGFR) mutations, anaplastic lymphoma kinase (ALK) tests, and next-generation sequencing (NGS), were included. Scattered information was integrated and automatically built up to match the cohort, allowing users to capture the most updated test results and treatment outcomes.
Conclusions: This landmark study documented the successful construction of a real-time updating system for medical big data, based on the CDW program.
2021 Translational Lung Cancer Research. All rights reserved.
In plain English
The authors described ROOT, a computer system they built at the Samsung Medical Center in Seoul, Republic of Korea. It automatically pulled data from hospital electronic records and organized them for cancer research. It covered 67,617 patients diagnosed from January 2008 to January 2020: 28,954 with non-small cell lung cancer, 2,540 with small cell lung cancer, 30,035 with head and neck cancer, 4,950 with esophageal cancer, 966 with thymic cancer and 172 with mesothelioma. The system gathered more than 700 clinical data points, processed free text and updated every 24 hours. In a check, 200 randomly selected patients per cohort were compared against medical records. Clinical stage was confirmed in 95.6% of non-small cell lung cancer patients, and survival data were more than 95% accurate. Recurrence data for stage I to III non-small cell lung cancer patients after curative-intent surgery were 95% accurate. The article did not study asbestos and gave no mesothelioma results beyond that cohort count. The authors concluded the system was successfully developed but still at an early stage.
We wrote this plain-English summary from the full article with the help of AI, and a second AI model checked each sentence against the article. It is not the authors' wording; the abstract and the article are their own account.
What the study did and found
- Design: Description of the development and validation of an automated hospital data collection system (not an epidemiological or clinical outcome study)
- Who was studied: 67,617 patients diagnosed at Samsung Medical Center, Seoul, from January 2008 to January 2020: 28,954 with non-small cell lung cancer, 2,540 with small cell lung cancer, 30,035 with head and neck cancer (23,578 of them thyroid cancer), 4,950 with esophageal cancer, 966 with thymic cancer and 172 with mesothelioma (site of mesothelioma not specified)
- Exposure: No asbestos, fiber or occupational exposure was studied
- Main results:
- Across the six main areas of each patient's cancer journey, the system collected more than 70 essential elements and 700 clinical data points
- Extracted data were automatically uploaded every 24 hours
- For validation, 200 patients were randomly selected from each cohort and compared with the actual medical records
- Clinical stage was confirmed in 95.6% of non-small cell lung cancer patients
- Survival data were more than 95% accurate and had no missing values
- Recurrence data, checked in stage I to III non-small cell lung cancer patients after curative-intent surgery, were 95% accurate compared with chart review by a medical oncologist
- The authors' conclusion: The authors concluded that they had successfully developed an algorithm to retrieve, analyze and automatically update clinical data warehouse data on a cancer patient cohort in real time
- Limitations the authors state:
- The system was at an early stage and had constraints in sensitivity and data specificity; algorithm development was ongoing
- Applying the algorithm to other organs, cancers or diseases would need to be checked for problems
Topics
Medical terms in this study, explained in our Lexicon: Mesothelioma, Disease Level, Lung Cancer, Esophageal Cancer, EGFR, Next-Generation Sequencing (NGS).
Related studies
- Real-time measurement of fibers using an HY-differential mobility analyzer with an optical particle counter (KOFAM) — S. Choi, K. Jang, et al. (2017)
- Association between hospital finances, payer mix, and complications after hyperthermic intraperitoneal chemotherapy: deficiencies in the current healthcare reimbursement system and future implications — M.H. Squires, C.A. Staley, et al. (2015)
- Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in the Chinese healthcare system — W. Lang, Y. He, et al. (2024)
- Data-driven information retrieval in heterogeneous collections of transcriptomics data links SIM2s to malignant pleural mesothelioma — J. Caldas, N. Gehlenborg, et al. (2012)
- The incremental healthcare cost associated with cancer in Belgium: A registry-based data analysis — V. Gorasso, S. Vandevijvere, et al. (2024)
- Laying the Foundation for a Mesothelioma Patient Registry: Development of Data Collection Tools — J.M. Gaitens, M. Culligan, et al. (2023)
Browse more research in Translational Lung Cancer Research, or return to medical research.
How to cite it
Cite the study
H.A. Jung, O. Jeong, D.K. Chang, S. Park, J.M. Sun, S.H. Lee, et al. Real-time autOmatically updated data warehOuse in healThcare (ROOT): an innovative and automated data collection system. Translational Lung Cancer Research 2021;10(10):3865-3874. doi:10.21037/tlcr-21-531. PMID: 34858777.
Cite our summary
“Real-time autOmatically updated data warehOuse in healThcare (ROOT): an innovative and automated data collection system.” AsbestosClaims.Law Library. https://asbestosclaims.law/library/research/real-time-automatically-updated-data-warehouse-in-healthcare-root-an.
ACL Doc numbers and their short links never change. See how to cite the Library.
Talk with an asbestos lawyer
Start with what you remember, and we'll take it from there.
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.